MyFinsight
Home
Blog
About
Contact
Download
Download image
Available-for-sale marketable
securities
$155,160K
Cash and cash
equivalents
$124,093K
Prepaid expenses and
other current assets
$3,700K
Property and equipment,
gross
$5,296K
Total current assets
$282,953K
Other non-current
assets
$4,903K
Operating lease
right-of-use assets
$3,568K
Property and equipment,
net
$1,546K
Restricted cash
$551K
Finance lease
right-of-use assets
$305K
Less accumulated
depreciation
$3,750K
Total assets
$293,826K
Total liabilities and
stockholders' equity
$293,826K
Total stockholders'
equity
$232,276K
Total liabilities
$61,550K
Accumulated deficit
-$424,827K
Additional paid-in capital
$657,005K
Total current
liabilities
$36,487K
Term loan
$24,743K
Operating lease
liabilities, net of...
$320K
Accumulated other
comprehensive income
$97K
Common stock, 0.00001
par value...
$1K
Other accrued
expenses and current...
$13,472K
Accrued compensation
$9,990K
Accounts payable
$5,306K
Accrued license expense
- related party
$3,750K
Operating lease
liabilities, short-term...
$3,662K
Finance lease
liabilities, short-term...
$307K
Back
Back
Balance Sheet
source: myfinsight.com
Kyverna Therapeutics, Inc. (KYTX)
Kyverna Therapeutics, Inc. (KYTX)